As we approach Valentine’s Day, wouldn’t it be nice to know how to turn up the “heat” and make our partner’s passions go into overdrive? One way to get those juices flowing is to use an aphrodisiac, which can be any food or drink that increases libido when consumed. Aphrodisiacs are distinct from substances that address fertility issues such as impotence or sexual dysfunction. From the Greek word aphrodisiac, or "pertaining to Aphrodite,” the idea comes from the goddess of love. But really, is the notion of using an aphrodisiac a bit too silly to make the bedroom pop? According to Board Certified NYC Internist and Gastroenterologist Dr. Niket Sonpal, “This concept is based on science, as traditionally it is known some foods possess chemical properties that could increase pheromones and heighten our interest and others may indirectly boost testosterone or estrogen levels, thereby increasing human sex drive. Others are considered arousing because of their appearance or texture.” In honor of Valentine's Day, Dr. Sonpal shares some of the foods commonly believed to have aphrodisiac powers.
Classically, to be considered an aphrodisiac, a substance should:
Consumed orally
Reliably increase libido or sexual desire (no placebo effect, no diminished libido)
Take effect relatively immediate
The Top Aphrodisiac Delicacies
Oysters
One of the most infamous aphrodisiacs, as their appearance mimics the labial folds of a vagina; oysters are high in zinc and have a reputation for being great for love and fertility. Researchers found that oysters contain amino acids that trigger the production of sex hormones. Dr. Sonpal says that “Oysters offer a lean source of protein to help give you energy all night long and, in addition to offering the body zinc, which helps blood flow and nourishes sperm, there's scientific evidence that an amino acid found in oysters may directly raise sexual hormone levels."
Pistachio Nuts: These have been around for many years. They have many health benefits as they contain protein and fiber. Nevertheless, they also help to reduce symptoms of erectile dysfunction. This could be due to the fact that pistachios lower cholesterol and stimulate blood flow throughout the body.
Chai Tea
Skip the coffee after dinner and reach for a cup of Indian chai tea. The typical spices in this brew include ginger, cloves, and cinnamon, all come from exotic places and certainly will get the blood flowing, and it has almost no caffeine so the stimulant effect is less than coffee, so you'll still be able to drift off to sleep with your lover after your lovemaking!
Chili Martini: Alcohol can be a great way to calm the nerves and get into the mood provided you don’t overdo it. Spice up your Valentine’s night with a chili martini. Thai chilies have been known to be an aphrodisiac for years because they cause your nerves to release epinephrine, which results in increased blood flow. Having a drink like this will defiantly stimulate your body and get you in the mood.
Red Wine: If you’re not feeling bold enough to try the chili martini, why not have red wine? Red wine will be sure to leave you feeling less awkward and aroused. The scent alone has been proven to get people in the mood. It is proven that wine decreases inflammation and gets your blood pumping.
Avocado: High levels of folic acid, vitamin B9, and B6 all provide your body with energy and even help to increase testosterone production. Food has been used throughout time to work as a way to increase sexual arousal. On top of their excellent taste, they have health and sexual benefits that could be used as a stimulant.
Asparagus: Like many other foods, asparagus increases blood and oxygen flow due to vitamin E and potassium in it. It also tends to stimulate the urinary tract system, which causes you to have an “itch” down there which some find arousing.
Bananas
With their phallic shape, bananas already look tempting and sensual; but they also contain bromelain, an enzyme which Dr. Sonpal says can trigger testosterone production. Its vitamin B can elevate energy levels and the high sugar content gives the brain a kick!
Chocolate
Scientists ascribe the aphrodisiac qualities of chocolate, to two chemicals it contains. One, tryptophan, is a building block of serotonin, a brain chemical involved in sexual arousal. The other, phenylethylamine, a stimulant related to amphetamine, is released in the brain when people fall in love.
About Dr. Niket Sonpal: Dr. Niket Sonpal is an Adjunct Assistant Professor at Touro College of Osteopathic Medicine and Clinical instructor at Kingsbrook Jewish Medical Center, Brooklyn who specializes in Gastroenterology. He is a graduate of the Medical University of Silesia – Hope Medical Institute in Poland. After completing his residency in Internal Medicine at Lenox Hill Hospital, he was selected to be the 2013‐2014 Chief Resident at Lenox Hill Hospital–Northshore LIJ Health System. Dr. Sonpal has completed his Fellowship in Gastroenterology & Hepatology at Lenox Hill Hospital and continues his work in the field of medical student and resident test preparation. He now serves as the associate program director for the Internal Medicine Residency Program at Brookdale University medical center.
He is the co‐author for the best-selling Master the Boards: USMLE Step 2 CK, Master the Boards Step 3, And Master the Boards: Internal Medicine. He is also the Chief Operating Officer for Medquest Test Prep, Director of Medical Education for Picmonic Test Prep, and a recognized expert on medical test prep.
Visual disturbances in sildenafil users
Study reports persistent visual disturbances in men taking the highest recommended dose of sildenafil, suggesting that first-time users should use a lower dose
Sildenafil is commonly used to treat erectile dysfunction and is generally regarded as safe with limited side effects. However, a recent study in Frontiers in Neurology has highlighted the risk of persistent visual side-effects, such as light sensitivity and color vision impairment, in men who have taken the highest recommended dose of sildenafil. While these effects appear to be rare, the research suggests that first-time sildenafil users should start with a lower dose before increasing it, if necessary.
Erectile dysfunction can have significant psychological consequences for men who are affected by it, and it can make fulfilling sexual relationships more difficult to achieve. Sildenafil became available in 1998 as a treatment for erectile dysfunction. It soon became the fastest selling drug in history, demonstrating the phenomenal demand for treatments that enhance sexual performance.
Originally developed as a treatment for high blood pressure, the drug dilates blood vessels and relaxes smooth muscle in the penis, making it easier to achieve and maintain an erection. The effects of the drug normally last 3–5 hours and although side-effects such as headache and blurred vision occasionally occur, they usually disappear relatively quickly.
However, Dr. Cüneyt Karaarslan of the Dünyagöz Adana hospital in Turkey, noticed a pattern in 17 male patients who attended the hospital. In the new study, Karaarslan reports that the patients suffered numerous visual disturbances, including abnormally dilated pupils, blurred vision, light sensitivity, and color vision disturbances, which included intensely blue colored vision with red/green color blindness.
All 17 patients had taken sildenafil for the first time, and all took the highest recommended dose of 100 mg. None of the men had been prescribed the medication. The visual side-effects began once the drug took effect, and were still present when the men arrived at the clinic 24-48 hours later.
The doctors in the clinic conducted various eye tests and monitored the patients over time to see how their symptoms developed. Fortunately, in all 17 patients the symptoms had cleared up by 21 days later, but this was doubtless a difficult experience for the men involved.
“Many men use non-prescription performance enhancing drugs to help with sexual anxiety and erectile dysfunction,” said Karaarslan. “For the vast majority of men, any side-effects will be temporary and mild. However, I wanted to highlight that persistent eye and vision problems may be encountered for a small number of users.”
So, why were these men susceptible to such long-lived side-effects? It may be possible that a small subsection of the population does not break sildenafil down and eliminate it from the body efficiently, leading to very high concentrations in the blood compared with most users.
These men also took the highest recommended dose of sildenafil on their first time taking the drug. Starting with a lower dose may have meant less severe side-effects. In addition, taking the drug under medical supervision would likely have meant that the men would not have used such a high dose on their first time.
So, if you are struggling with erectile dysfunction, should you be worried about trying sildenafil? In short, no. Such persistent side-effects appear to be very rare. However, it is always best practice to consult your physician first, it may be best not to start at the highest dose, and in case you are particularly sensitive, consider first using the drug under medical supervision.
“Although these drugs, when used under the control of physicians and at the recommended doses, provide very important sexual and mental support, uncontrolled and inappropriate doses should not be used or repeated,” said Karaarslan.
Toning and sculpting arms is an important part of any workout regimen. Those prominent arm muscles are not only a great way to show off your hard work but also boost your performance in many sports. However, arms are also one of the more delicate and injury-prone parts of your body. Read on to learn about four common arm injuries and how to treat and prevent them.
Rotator Cuff Tear
The rotator cuff is a group of muscles and tendons that assist with lifting and rotating your arm. These muscles and tendons often tear during throwing sports like baseball and basketball or while lifting weights. Mild to moderate tears are treated with rest, pain medications and physical therapy, while a severe injury may require surgery. Prevent a rotator cuff tear with proper stretching before working out and using good form when lifting weights or playing sports.
Bicep Tendonitis
Many fitness fanatics want bulging biceps to show off, but overworking this muscle can lead to painful inflammation called tendonitis. Bicep tendonitis is treated by using an upper arm sleeve to compress the muscle and NSAID medications like ibuprofen or naproxen to reduce inflammation. To avoid this injury, stretch and warm up your biceps before working out and don’t lift more weight than you can handle.
Sprained Wrist
Wrist sprains are a common result of catching yourself with outstretched arms during a fall. Most sprains are mild and heal with a week or two of rest, ice and compression. However, severe sprains may require weeks of immobilization followed by physical therapy. If you participate in an activity like ice skating or gymnastics where falls are common, learn how to fall with proper technique to prevent wrist sprains. Wearing wrist supports while working out can also help.
Tennis Elbow
You don’t have to play tennis to get tennis elbow. This repetitive strain injury to the elbow and forearm causes inflammation and loss of mobility and is treated with rest, immobilization and physical therapy. Severe cases may require orthotic devices or surgery. Reduce your risk of tennis elbow by taking a break if you feel soreness and using exercises to build strength in your forearms.
Do you suffer from repeated arm, wrist and shoulder injuries? Sustaining the same injury over and over is a sign that you need to improve your workout technique. Consider working with an experienced trainer or physical therapist to learn how to exercise without straining your body or injuring yourself.
Breakthrough in Body Contouring Makes National Debut at Offices of Renown Miami Based Plastic Surgeon,
Dr. Adam J. Rubinstein, MD, FACS
February 2020—Miami, Florida -- Board-certified, Miami plastic surgeon, Dr. Adam J. Rubinstein, MD, FACS, announces the national debut of EON FR (Fat Reduction). EON FR technology for body contouring is the world’s first non-invasive, non-contact body sculpting devise that is FDA cleared for abdominal fat reduction. EON FR is unique, innovative and 100% safe, effectively delivering laser energy to treat the adipose tissue for fat reduction and body sculpting with no fuss, no pain, no post-treatment massages and no patient down time!
Unlike other non-invasive fat reduction procedures, EON FR takes about 15 minutes and treats 6x more surface area than the market leader. EON FR does not require applicators or gels. Before performing the treatment, Dr. Rubinstein determines the area for body contouring then the EON FR maps the patient’s topography. It actually scans and adjusts to the exact shape of the patient’s body. The new device uses an articulated robotic arm that delivers laser energy to the targeted area while patient comfort is maintained with a patent-pending cooling system. Laser energy from EON FR induces apoptosis, a process in which the body naturally eliminates fat cells through its lymphatic system with optimal results seen after just 12 weeks. In a clinical study, all patients received an average fat reduction of 15.1% and over 39% achieved between 20—45% fat reduction in a single treatment. “The is truly 21st century tech. Non-contact, robotics, state of the art cooling, it has everything a patient would want.” says Dr Adam Rubinstein. “EON FR offers a pain-free treatment that is customized to the patient’s body and completed comfortably in 15 minutes. This is a huge breakthrough. I’m proud to be among the first to offer this to my patients,” he adds.
About Dr Adam J. Rubinstein
Dr Adam J. Rubinstein is a Board Certified and Award-Winning Plastic Surgeon. He has served as the Chief of Plastic Surgery and Chief of the Department of Surgery for Jackson North Medical Center in Miami, FL. Dr Rubinstein specializes in whole body surgical & non-surgical cosmetic treatments for both women and men. He can discuss the latest innovations and procedures to help people make proper and informed choices. Dr. Rubinstein is also a patient advocate and is passionate about sharing the good, the bad and the ugly about common plastic surgery practices to help patients navigate the world of plastic surgery effectively and safely. His goal is to help people make their best choices about the latest and most innovative procedures. He is also an outspoken patient advocate and believes people have the right to know to make informed choices. You can learn more on his social channels including his Instagram accounts, @drrubinstein and @plasticsurgerytruths, SnapChat @drrubinstein, and Facebook page @MiamiPlasticSurgeon. www.dr-rubinstein.com
About Eon
EON FR’s body contouring technology is fast, easy to use, and covers a larger surface area. Dominion develops disruptive aesthetic technologies to meet the needs of aesthetic physicians.
Dominion Aesthetic Technologies, Inc. (Dominion) is a laser platform medical device company headquartered in San Antonio, TX, with technical labs in Orlando, Fl.
Dominion’s product EON FR, the world’s first non-invasive, non-contact body contouring device is FDA cleared for full abdominal fat reduction (FR).
The company’s purpose is to offer the best solutions for aesthetic physicians and practitioners. In developing new products, it utilizes the knowledge of its Scientific Advisory Committee comprised of world-renowned experts. The company designs, builds and commercializes high technology aesthetic devices.
EMD Serono Receives Positive Recommendation for MAVENCLAD® (cladribine tablets) for the treatment of Relapsing-Remitting Multiple Sclerosis from the Institut national d'excellence en santé et en services sociaux (INESSS)
This decision brings PrMAVENCLAD® (cladribine tablets) closer to broader access for eligible patients living with Relapsing-Remitting Multiple Sclerosis in the province of Quebec
MISSISSAUGA, ON, Feb. 6, 2020 /CNW/ - EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and Canada, today announced that it received a positive recommendation from the Institut national d'excellence en santé et en services sociaux (INESSS) for MAVENCLAD (cladribine tablets). MAVENCLAD was approved by Health Canada in November 2017 as monotherapy for the treatment of adult patients with relapsing-remitting multiple sclerosis (RRMS) to reduce the frequency of clinical exacerbations and delay the progression of disability.i
With the positive assessment of the therapeutic value of MAVENCLAD from INESSS to Quebec's Minister of Health and Social Services, EMD Serono will now work with the Ministère de la Santé et des Services sociaux to include MAVENCLAD on the Régie de l'assurance maladie du Québec (RAMQ) List of Medications. Once included on the RAMQ List of Medications, eligible patients living in the province of Quebec will have equitable access to MAVENCLAD as a treatment option for RRMS, which is currently reimbursed by most private drug insurance plans.
"We are delighted with the positive recommendation from INESSS, which recognizes the therapeutic value of MAVENCLAD and the need for this treatment option for eligible patients who live with RRMS," said Gaby Murphy, President & Managing Director, EMD Serono, Canada. "We welcome this as an important step to ensure broader and equitable access to MAVENCLAD in the province of Quebec."
"Some 20,000 people in Quebec alone are living with MS, and the INESSS recommendation for MAVENCLAD is great news for patients," said Louis Adam, Executive Director of the Quebec and Atlantic Division of the MS Society of Canada. "Having access to new and innovative treatment options is important for people living with MS in the province of Quebec, and we are delighted by this positive step forward."
Canada has one of the highest rates of MS in the world, with one in 385 people living with the disease.ii EMD Serono, Canada is deeply committed to people living with MS, and to leading innovation within the MS space.
About MAVENCLAD MAVENCLAD (cladribine tablets) is a short-course oral therapy that selectively and periodically targets lymphocytes thought to be integral to the pathological process of relapsing MS.iii In November 2017, Health Canada approved MAVENCLAD (cladribine tablets) as monotherapy for the treatment of adult patients with RRMS to reduce the frequency of clinical exacerbations and delay the progression of disability. MAVENCLAD is generally recommended in MS patients who have had an inadequate response to, or are unable to tolerate, one or more therapies for multiple sclerosis.
MAVENCLAD has been approved in over 70 countries including the United States, European Union (EU), Australia and Switzerland, for various relapsing MS indications.
The clinical development program of MAVENCLAD in MS comprises more than 12,000 patient years of data with over 2,700 patients included in the clinical trial program, and up to 10 years of observation in some patients. These clinical trials include the Phase III CLARITY, CLARITY extension and ORACLE MS trials, the Phase II ONWARD trial and the PREMIERE Long-term Safety Registry.
About Multiple Sclerosis Multiple Sclerosis (MS) is a degenerative autoimmune disease in which the myelin sheath around the nerves in the brain and spinal cord are inflamed and often damaged.iv It is estimated that approximately 2.3 million people have MS worldwide.vCanada has one of the highest rates of MS in the world with one in 385 people living with the disease.vi While symptoms vary, the most common symptoms of MS include extreme fatigue, lack of coordination, weakness, tingling, impaired sensation, vision problems, bladder problems, cognitive impairment and mood changes.vii The relapsing forms of MS are the most common type at the time of diagnosis.viii
About EMD Serono, Canada EMD Serono, Canada, is the Canadian biopharmaceutical business of Merck KGaA, Darmstadt, Germany. EMD Serono, Canada has integrated cutting-edge science, innovative products and devices, and industry-leading patient support and access programs. EMD Serono, Canada has deep expertise in neurology, fertility and endocrinology, as well as a robust pipeline of potential therapies in neurology, oncology, immunology and immuno-oncology. Today, EMD Serono, Canada has more than 100 employees across Canada with headquarters in Mississauga, Ontario.
About Merck KGaA, Darmstadt, Germany Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across healthcare, life science and performance materials. Around 56,000 employees work to make a positive difference to millions of people's lives every day by creating more joyful and sustainable ways to live. From advancing gene editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2018, Merck KGaA, Darmstadt, Germany, generated sales of € 14.8 billion in 66 countries.
The company holds the global rights to the name and trademark "Merck" internationally. The only exceptions are the United States and Canada, where the business sectors of Merck KGaA, Darmstadt, Germany operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Performance Materials. Since its founding in 1668, scientific exploration and responsible entrepreneurship have been key to the company's technological and scientific advances. To this day, the founding family remains the majority owner of the publicly listed company.
or to arrange an interview, please contact: Hibaq Ali, Weber Shandwick Canada, 416.642.7915, hali@webershandwick.com; Smita Devane-Bhan, Associate Director of Communications, EMD Serono Canada, 905.483.3860, smita.devane-bhan@emdserono.com
BioSteel Named Official Sports Drink of the Brooklyn Nets and Barclays Center
BROOKLYN, NY, Feb. 6, 2020 /CNW/ - BioSteel Sports Nutrition Inc. ("BioSteel") has been named The Official Sports Drink of the Brooklyn Nets and Barclays Center, the company's first major partnership with a professional U.S. sports team.
The multi-year agreement includes significant BioSteel branding at Barclays Center for all Nets games, as well as signage integrated at HSS Training Center, the Nets' state-of-the-art practice facility in Brooklyn. Integration at these facilities will incorporate a variety of elements such as digital and static signage throughout the venues, including the media backdrops, and the centerhung scoreboard at Barclays Center. In the second year of the partnership, BioSteel will receive branding on the Nets' and visiting teams' benches during all of the team's home games.
Founded in 2009, BioSteel's focus on premium natural ingredients, product transparency, and identifying the essential nutrients needed to power physical activity has led to the brand achieving a reputation for being the hydration product provider of choice for high-performance athletes.
"The Brooklyn Nets have been using BioSteel products for years, and becoming our official sports drink partner is a natural evolution of our relationship," said Bryan Calka, Senior Vice President of Global Partnerships at BSE Global. "Sports nutrition is of the utmost importance to our team, and we are looking forward to expanding our work with BioSteel as it continues to lead the way in nutritional support for athletes everywhere."
"We commend the Brooklyn Nets for making a healthy choice by partnering with a sugar-free sports drink company," said Co-CEO, Co-Founder, and former NHLer, Michael Cammalleri. "With this alliance, BioSteel tips off one of many major US-based marketing initiatives that we will be rolling out this year as we rapidly expand our presence in the United States."
Originally formulated for professional athletes, BioSteel's products have gained mainstream popularity due to the authenticity of the brand's partnerships and the quality and efficacy of its products. This relationship allows BioSteel to continue to tell an authentic story that started in the locker room and is now spilling over to the mass retail market.
ABOUT BIOSTEEL BioSteel is a North American operated sports nutrition company that was built on the mandate of providing the safest, healthiest, and most effective line of nutritional products available. BioSteel's line of nutritional products ranges from a sugar and caffeine free sports beverage with no artificial flavors, colors, or preservatives, to a line of proteins and everyday essentials. BioSteel products are currently readily available across North America, and globally with select retail partners or direct to consumers online, through www.biosteel.com.
ABOUT BSE GLOBAL BSE Global manages and operates Barclays Center, the Brooklyn Nets, its NBA G League team, the Long Island Nets, and its NBA 2K League affiliate, NetsGC. The company also includes the WNBA's New York Liberty. Through programming, marketing, sales, and operations, BSE Global delivers dynamic content and experiences for audiences.
SOURCE BioSteel Sports Nutrition Inc.
Survivors in Canada are Taking Steps to Reduce the Risk of Another Heart Attack. But is it Enough?
New Amgen Survey Shows Heart Attack Survivors in Canada Do Not Know Their Cholesterol Level or What It Should Be
MISSISSAUGA, ON, Feb. 6, 2020 /CNW/ - In recognition of February as Heart Month, Amgen Canada ("Amgen") today released Canadian findings as part of a global survey1 that evaluated worldwide heart attack survivors' perceptions and awareness of the connection between cholesterol and cardiovascular (CV) events revealing that 56 per cent of respondents in Canada do not consider high cholesterol to be a chronic condition requiring long-term management and care.2
Low-density lipoprotein cholesterol (LDL-C), or "bad" cholesterol, is one of the most important modifiable risk factors for heart attack.3 Globally more than 40% of patients who have had a CV event, like a heart attack, will go on to have another within two years.4
The survey's findings show that while heart attack survivors are proactively trying to improve their cardiovascular health, they may not fully understand the importance of lowering high LDL-C to reduce their risk of another heart attack:
Sixty-two per cent of survey respondents report being mindful about what they eat, 60 per cent monitor their blood pressure and 55 per cent are conscious of their weight.5
However, confusion remains when it comes to lowering cholesterol. Only one in two heart attack survivors know both their current and target cholesterol level; and of survivors living with high cholesterol, 88 per cent do not consider it to be a leading risk factor for another event.6
"Cardiovascular disease remains one of the most significant health challenges in Canada where an estimated 63,200 adults will experience a first heart attack this year7," said Ponda Motsepe-Ditshego, Executive Medical Director at Amgen Canada. "This survey shows patients want to reduce their risk of another heart attack, but are unsure about the best actions to take. This Heart Month we're urging high-risk patients to talk to their doctor and learn more about the connection between high cholesterol and the risk of a repeat heart attack as well as how they can lower their cholesterol levels."
The survey of more than 3,200 heart attack survivors across 13 countries, including 250 people in Canada – revealed that patients might not be having the right conversations with their doctors. Additional key findings included:
Fifty-six per cent of surveyed Canadians do not believe high cholesterol is a chronic condition requiring long-term care.2
While 88 per cent of patients have had their cholesterol checked in the last year by a physician, only six out of ten patients have discussed the role of cholesterol in heart attacks with their healthcare professional.6
Globally, approximately 8 of 10 very high-risk adults are still unable to attain their LDL-C goal despite lipid-lowering therapy.8Professional cardiology societies around the world now recognize that lower cholesterol reduces the risk of another CV event, which is reflected in updated treatment guidelines for high-risk patients. Newer, more potent treatment options are the only way for these high-risk patients to achieve recommended cholesterol levels that can help reduce their risk of another heart attack.
Amgen encourages heart attack survivors or anyone concerned about their cardiovascular health to spend this Heart Month learning about cholesterol. But a heart-healthy lifestyle is an ongoing process, so talk to your doctor to learn more about how you can improve your heart health and reduce your risk of life-changing CV events.
About the Survey
The research was commissioned by Amgen and conducted by KRC Research, an independent global public opinion research consultancy. A total of 3,236 online surveys were completed by post-myocardial infarction (MI) patients aged 40 or older in 13 different countries. Two hundred and fifty heart attack survivors were surveyed in Canada. Participating countries included the United States, Mexico, Brazil, Canada, United Kingdom, France, Germany, Spain, Italy, the Netherlands, China, South Korea, and Japan. The survey included approximately 250 MI patients from each participating country. Data collection took place from June 21 to July 18, 2019.
About Heart Month
February is Heart Month, a time to bring attention to the importance of cardiovascular health, and what we can do to reduce our risk of cardiovascular disease.9
Heart disease affects approximately 2.4 million Canadian adults, and is the second leading cause of death in Canada.10
About Amgen Canada
As a leader in innovation, Amgen Canada understands the value of science. With main operations located in Mississauga, Ont.'s vibrant biomedical cluster, and its research facility in Burnaby, B.C., Amgen Canada has been an important contributor to advancements in science and innovation in Canada since 1991. The company contributes to the development of new therapies and new uses for existing medicines in partnership with many of Canada's leading health-care, academic, research, government and patient organizations. To learn more about Amgen Canada, visit www.amgen.ca.
References
_____________________________________
1 Amgen "Global Cholesterol Disease State Education Survey: Understanding Patient Attitudes Towards Risk of Recurrence and Cholesterol Management, 2019".
2 Amgen "Global Cholesterol Disease State Education Survey" Country Highlights: Canada. Page 8.
8 Gitt A, Lautsch D, Ferrieres J, et al. Low-density lipoprotein cholesterol in a global cohort of 57,885 statin-treated patients. Atherosclerosis. 2016 Dec;255:200-209
The world of advertising and social media has brought physicians' names to the public continuingly. Years ago, if a doctor called him/herself a cosmetic surgeon, the patient knew precisely what that term meant. Doctors in various sub-specialties such as dermatologists, gynecologists, ophthalmologists, and even dentists are performing cosmetic surgery procedures. This can leave prospective patients utterly confused about how to find the best and most qualified surgeons But how, wonders Dr. Manish Shah who is an Ivy League educated Board-certified Plastic Surgeon in Denver, "is a prospective patient to know who is a diligent, excellent, caring physician and who is a charlatan?" Dr. Shah wants to disseminate information the public can use and heed as caution when selecting a cosmetic surgeon in a country now brimming with doctors who call themselves "cosmetic surgeons."
"Public law and policy do not necessarily protect us from unreasonable and untrue claims," says Dr. Shah. "A physician needs to be licensed in medicine -- which means earning a recognized medical degree, From that point, he or she can hang out a shingle in any specialty he/she chooses; the state does not control what area of medicine he/she practices or which type of specialist they claim unless there are complaints and they are brought before the Office of Professional Medical Conduct. Often, by then, it is too late."
What can we look for before placing ourselves under a physician's care to ascertain the qualities and qualifications of that physician? There are four basic areas that must be investigated to determine the qualifications of physicians. These are: a physician's training; a physician's certification; a physician's associations; and a physician's attitude toward his or her patients and the medical community at large.
"A physician should have and be willing to provide evidence that he or she has trained in the area of their expertise," says Dr. Shah. "For example, patients want to locate a plastic surgeon who trained in plastic surgery, which means a post-surgical residency fellowship in the sub-specialty. Each residency or fellowship program gives a certificate certifying the dates of service as well as the hospital and department in which the physician trained." Physicians are usually quite proud of their achievements and keep these and many other framed diplomas in their offices. If they are not available, then at least a curriculum vitae or a brochure describing a doctor's training should be available and should be carefully examined by the patient. "If a physician is either unable or unwilling to disclose this information, it becomes a clear issue of 'medical consumer beware,' says Dr. Shah.
After training in their chosen field, each medical or surgical sub-specialty has a certifying board that is approved by the American Board of Medical Specialists (ABMS). After spending the requisite number of years training, a physician has to take an examination in order to be certified. After being certified, a surgeon often applies to the American College of Surgeons for a fellowship. These credentials can be checked in libraries, hospital libraries, and online.
"For example, The American Board of Cosmetic Surgery is not approved by the American Board of Medical Specialists and neither are a host of other so-called 'boards,' advises Dr. Shah, who is board-certified with the American Board of Plastic Surgery which is the only plastic surgery board recognized by the ABMS. A gynecologist, ENT or general surgeon may be an exquisitely trained physician--but if they did cosmetic surgery, where did they learn to do it? Was it on-the-job training, or an online or weekend course? How often do they go for a refresher course? Are they affiliated with a certified hospital in case of an emergency? "
Dr. Shah advises the would-be medical consumer "not to be impressed by a P.C. after the physician's name--it only means that they are incorporated. Jane Doe, M.D., F.A.C.S.', on the other hand, actually tells one something about the qualifications of the physician." It means, Fellow of the American College of Surgeons) It indicates to the patient that the surgeon has passed a thorough evaluation of both professional competence and ethical fitness.
If patients are still confused, Dr. Shah advises them, "check a third area: A physician's associations and affiliations. If a physician is on the staff at a well-respected local teaching hospital in the department that is appropriate to their qualifications, then patients at least know that his or her qualifications have been appropriately researched by the hospital's committees and should, therefore, be valid and current. "Today, however, because of skyrocketing hospital costs, the trend is toward more out-patient surgery and care," says Dr. Shah. "Because of this, physicians have moved further away from the hospital. This may be good for the patient from a cost standpoint, but a well-qualified physician--especially a surgeon--should maintain a relationship with a hospital just in case there is a problem with a patient that requires hospitalization." Dr. Shah further advises patients to remember that, "when a physician is outside of an institutional setting, there is no quality control or peer review other than what the physician sets for himself."
Patients must look into many areas of a physician's training, especially certification, association, and personality prior to allowing a medical professional to manage their health care. "If you do your homework well," says Dr. Shah, "you should end up with a compassionate well-trained competent physician with whom you feel totally at ease and in whom you have the utmost confidence."
Since 1937, the ABPS has issued 9,499 certificates to plastic surgeons who met high standards in training requirements and successfully passed the examinations covering the breadth of Plastic Surgery. Approximately 6,900 are actively practicing.
About Dr. Manish Shah
Plastic Surgeon Colorado | Dr. Manish Shah, M.D. | Denver
Manish Shah, M.D., F.A.C.S. was born in Canada and raised in the Washington, D.C. area. He graduated with honors from the University of Pennsylvania, receiving a degree in biomedical engineering. He then completed his medical training at the University of Virginia, earning his Medical Doctorate. During this time he also completed a one-year fellowship in microsurgery research at the New York University School of Medicine / Institute of Reconstructive Plastic Surgery. As a prelude to his plastic surgery training, Dr. Shah completed a rigorous five-year training program in General and Trauma Surgery at Emory University and the Medical College of Georgia. His formal training in Plastic and Reconstructive Surgery was completed at the Univ. of Tennessee College of Medicine – Chattanooga Unit. After completing his plastic surgery training, he moved to New York City when he was selected for the prestigious Aesthetic Surgery Fellowship at Manhattan Eye, Ear, and Throat Hospital. He underwent extensive, advanced training in aesthetic surgery of the face, breasts, and body at the hands of some of the most renowned cosmetic surgeons in the world. This fellowship is widely considered to be the best of its kind in the world. Dr. Shah is one of only a select few plastic surgeons in the country who have undergone formal post-graduate training in aesthetic surgery.
Dr. Shah’s specialties include revision facial aesthetic surgery, rhinoplasty (“nose reshaping”), and aesthetic surgery of the breast (breast augmentation, breast lift, breast reduction). He is, however, well-trained in all areas of aesthetic surgery.
Dr. Shah’s aim is to obtain a natural appearing transformation that complements the real you!
Dr. Shah is a past Clinical Assistant Professor of Surgery at the University of Colorado Health Sciences Center based at Denver Health Medical Center, the Rocky Mountain region’s only academic Level I trauma center. He is a past Chief of Plastic Surgery at Denver Health Medical Center. He also maintains a private practice in Aesthetic and Reconstructive Plastic Surgery on the Dry Creek Medical Center campus (DTC/Denver) and up in the Aspen Valley (Basalt – in the office of MDAesthetics – Tim Kruse, M.D.).
Dr. Shah is a member of the American Society of Plastic Surgeons, the American Society of Aesthetic Plastic Surgery and the International Society of Aesthetic Plastic Surgery.
Dr. Shah is board-certified by the American Board of Plastic Surgery.
Arthritis Research Canada shows lupus patients who take their medications at lower risk for type 2 diabetes
VANCOUVER, Feb. 5, 2020 /CNW/ - An Arthritis Research Canada study has revealed good news for patients with lupus - showing that those who take their medications as prescribed, have a reduced risk of developing type 2 diabetes, compared to lupus patients who do not.
Lupus is a chronic autoimmune disease that affects several parts of the body. It's considered "the disease of a thousand faces" because symptoms change often and vary from person to person. Currently, there is no cure for lupus. Medications for lupus are primarily focused on easing a patient's symptoms and reducing inflammation. Hydroxychloroquine a medicine used to treat malaria and for patients dealing with lupus flares, also has the ability to potentially reduce the risk of type 2 diabetes.
Using British Columbia health data that includes information on prescriptions, healthcare visits, and hospitalizations – Arthritis Research Canada research scientist, Dr. Mary De Vera and her team studied lupus patients over four years. They found that compared to those who did not take their medications as prescribed, namely hydroxychloroquine, those who did - had a lower risk of developing type 2 diabetes.
"This research suggests a 39% lower risk of developing type 2 diabetes among lupus patients who took their medications as prescribed, in terms of following the dosing instructions and staying on the medication," De Vera said.
"This study is important because although we know from our prior research that an average of 43% to 75% of lupus patients do not take their medications as prescribed," she states, "There is actually limited evidence on how this impacts patient outcomes."
The study targeted type 2 diabetes as a known complication of lupus and is the first study to evaluate the link between non-adherence to antimalarial medication (hydroxychloroquine) and lupus patients. This is definitely important information for all people with lupus, to help improve their health and the quality and length of life.
About ARTHRITIS RESEARCH CANADA: Arthritis Research Canada is the largest clinical arthritis research institution in North America. Our mission is to transform the lives of people living with arthritis through research and engagement. Led by world-renowned rheumatologist, Dr. John Esdaile, Arthritis Research Canada's scientific team of over 100 are creating a future where people living with arthritis are empowered to triumph over pain and disability. With four centres across Canada in British Columbia, Alberta and Quebec (Laval and McGill Universities), Arthritis Research Canada is leading research aimed at arthritis prevention, early diagnosis, new and better treatment, and improved quality of life.
SOURCE Arthritis Research Canada
CAE supports state-of-the-art healthcare training at the MUHC
A global leader in training is helping to build Canada's best skilled team in healthcare
MONTREAL, Feb. 5, 2020 /CNW Telbec/ - The McGill University Health Centre (MUHC) Foundation and CAE are pleased to announce a collaboration that offers innovative solutions to transform patient care. The Montreal-based worldwide provider in healthcare education and training is donating $500,000, including state-of-the-art training simulation equipment and curriculum, in support of the MUHC's visionary project to elevate lifesaving skills and teamwork through its new Interprofessional Skills & Simulation Network.
Contributing to building Canada's best skilled team at the MUHC is all part of CAE's mission to make healthcare safer. From augmented reality to patient simulators, they are working with the MUHC's expert clinicians and renowned simulation educators to improve healthcare outcomes.
"At CAE, we are driven by our mission to make healthcare safer and are committed to improving clinical education and patient safety through simulation-based training solutions," says CAE's President and Chief Executive Officer Marc Parent, who sits on the MUHC Foundation's Board of Directors and is Co-Chair of the MUHC Foundation's Dream Big Campaign. "We are honoured to help equip the MUHC with the best technology and tools they need so they can practice the most advanced forms of medicine and provide the best patient care in the country."
Recognized internationally as a leading teaching hospital, the MUHC trains thousands of medical students, residents, nurses, allied health professionals and researchers the essential skills to serve patients across Quebec, Canada and around the world. With the Interprofessional Skills and Simulation Network, all of these medical professionals will train together in their own clinical environment to create effective interprofessional healthcare teams.
"New technology is disrupting medicine and the MUHC wants to take full advantage of it. We are transforming the way we teach using simulation as well as virtual and augmented reality, and AI-enhanced technologies to elevate lifesaving skills and teamwork," says Dr. Elene Khalil, Director of Education and Medical Co-Director Emergency Preparedness at the MUHC. "The MUHC is seizing the lead in developing tomorrow's essential healthcare skills, and in so doing we'll improve care not just for MUHC patients, we'll help to advance skills acquisition across Canada and beyond."
The MUHC Foundation is raising $10 million to create the MUHC Interprofessional Skills & Simulation Network as part of its Dream Big Campaign, co-chaired by Marc Parent, Suzanne Legge Orr and Jean Charest.
"This generous donation will allow the MUHC and Montreal to take the lead in transforming the education model to better respond to the new hospitals of the future," says Jean Charest. "With CAE's training expertise, the hospital will be able to set benchmarks, test emerging tools, and ultimately improve patient care."
This donation marks a unique partnership between industry and healthcare that represents a trend in hospital innovation.
"CAE Healthcare's commitment to improving the safety of patients through simulation-based training is evidenced in this partnership," says Suzanne Legge Orr. "Our hospital, our patients, and our community are going to be the first to see the impact."
Norman Steinberg, Chairman of the Board of the MUHC Foundation thanks CAE and Marc Parent for taking a leadership role in the Dream Big Campaign, which has already raised more than $52 million to support clinical research. "This campaign is not only about the health of Montrealers, but about making the MUHC a nationwide example for excellence in patient care, and having a global impact in healthcare innovation."
*** CAE and the MUHC Foundation are proud to present a video about the impact of simulation-based training on health professionals' readiness and patient outcome: https://www.cae.com/mediakit/
About the McGill University Health Centre (MUHC) The McGill University Health Centre (MUHC) is one of the best university hospitals offering tertiary and quaternary (complex) care. With the medical leadership of its founding hospitals, the MUHC offers multidisciplinary care, exceptional quality, focused on the needs of the patient in a bilingual environment. Affiliated with the Faculty of Medicine at McGill University and at the head of RUIS-McGill, the MUHC contributes to the evolution of pediatric and adult medicine by attracting scientific and clinical leaders from around the world, by evaluating cutting edge medical technologies and training the health professionals of tomorrow. In collaboration with our partners, we are building a better future for our patients and their families; for our employees, professionals, researchers and students; for our community and most importantly, for life. www.cusm.ca
About the McGill University Health Centre (MUHC) Foundation The MUHC Foundation raises funds to support excellence in patient care, research and teaching at the MUHC. The $10 million Dream Big: Build Canada's Best Skilled Team project will accelerate health care education and recruitment by establishing the MUHC Interprofessional Skills & Simulation Network. This project is part of the Foundation's larger Dream Big Campaign, which is working to change the course of lives and medicine and establish the MUHC and Montreal as a hub for innovation in health care and research across Canada. www.muhcfoundation.com
About CAE Healthcare CAE Healthcare offers integrated education and training solutions to healthcare students and clinical professionals across the professional life cycle, allowing them to develop practical experience in simulated environments before treating patients. CAE Healthcare's full spectrum of simulation solutions includes surgical and imaging simulation, curriculum, the CAE LearningSpace audiovisual and center management platform and highly realistic adult, pediatric and baby patient simulators. Today, hospitals, medical schools, nursing schools, defence forces and societies in more than 80 countries use our training solutions to make healthcare safer. cae.com/healthcare
About CAE CAE is a global leader in training for the civil aviation, defence and security, and healthcare markets. Backed by a record of more than 70 years of industry firsts, we continue to help define global training standards with our innovative virtual-to-live training solutions to make flying safer, maintain defence force readiness and enhance patient safety. We have the broadest global presence in the industry, with over 10,000 employees, 160 sites and training locations in over 35 countries. Each year, we train more than 220,000 civil and defence crewmembers, including more than 135,000 pilots, and thousands of healthcare professionals worldwide. www.cae.com
Follow us on Twitter: CAE_Inc.
SOURCE CAE INC.
TRAIN IT RIGHT NEWSLETTER
Sign Up and get a free 7 day Train it Right HIIT Program!
